Pipelines under the microscope for GSK and AstraZeneca
Rio Tinto and Anglo American dig deeper into copper growth.
Investment budgets in focus for Amazon, Meta and Microsoft
Rolls-Royce looking to fly towards its full-year targets.
AstraZeneca and GSK – Q2 results, Monday 27th and Tuesday 28th July
Derren Nathan, head of equity research, Hargreaves Lansdown
“Half-year readouts for the UK’s largest pharmaceutical giants will not only shine a light on their financial health but also progress within the laboratory. AstraZeneca’s recent late-stage setback with heart-disease medicine Wainua was a reminder that drug development is never risk-free, but such misses have been relatively rare given its strong pipeline record. It’s unlikely to threaten medium-term guidance, but it raises the bar for the rest of the pipeline if upgrades are to come through. GSK’s had its own disappointment, leading it to abandon its development of refractory chronic cough drug camlipixant which it acquired through a $2bn acquisition back in 2023.
Both companies need to keep driving new revenue opportunities, particularly as exclusivity expires on older treatments. Investors will want to see evidence of healthy spending on R&D. Acquisitions and partnerships are another route to filling the hopper. GSK recently completed the $10.6bn takeover of Nuvalent. AstraZeneca’s been busy with smaller acquisitions and licensing deals. There are plenty of good reasons for Big Pharma to keep spending, and investors will want reassurance that cash generation and balance sheet strength can support continued investment.”
Rio Tinto and Anglo American – Half year results, Wednesday 29th and Thursday 30th July
Derren Nathan, head of equity research, Hargreaves Lansdown
“Rio Tinto and Anglo American report against a supportive backdrop for copper, with prices still benefiting from demand linked to electrification, grid upgrades, data centres and constrained supply. That should provide a helpful tailwind to earnings, but investors will be just as focused on how both groups plan to grow exposure to one of mining’s most attractive long-term markets.
For Anglo American, the tie-up with Teck is the clearest signal of intent. The deal would create one of the world’s leading copper producers and shift the portfolio further towards future-facing commodities, at a time when Anglo is already reshaping the business around higher-quality assets. Investors will want reassurance that the strategic logic remains intact, while also keeping an eye on execution risk and balance sheet discipline.
Rio Tinto’s route is more heavily weighted to organic growth. Its Oyu Tolgoi mine in Mongolia remains a major long-term copper growth driver, while the Resolution project in the US and the Winu project in Western Australia offer further potential, albeit with long development timelines and permitting challenges. With copper demand increasingly tied to the buildout of digital and energy infrastructure, progress on these projects could matter just as much as the latest production numbers.”
Amazon, Meta and Microsoft – Q2 and Q4 results, Wednesday 29th and Thursday 30th July
Matt Britzman, senior equity analyst, Hargreaves Lansdown
“Next week’s Amazon, Meta and Microsoft results will put the AI spending boom back under the microscope. Markets remain uneasy about the sheer scale of investment, particularly when higher capital expenditure weighs on near-term cash flow. But for the wider AI trade, the most important signals will be continued customer wins, strong demand for computing power and confidence that the infrastructure buildout is continuing at scale. Any sign that projects are being delayed or budgets trimmed would raise questions across the AI supply chain. We expect the opposite, with current spending plans likely to rise as demand continues to outpace available capacity.
Cloud will be the clearest test of whether that spending is translating into growth. Investors will want to see Azure and AWS maintain their recent momentum, supported by strong demand for AI services and improving access to new capacity. Meta doesn’t have a cloud business today, which makes its spending harder for markets to value. That could start to change if management provides more detail on plans to rent computing power to outside customers or sign large cloud agreements. Even early signs of progress would give investors a clearer route from Meta’s vast infrastructure budget to a new source of revenue beyond advertising.”
Rolls-Royce – Half year results, Thursday 30th July
Aarin Chiekrie, equity analyst, Hargreaves Lansdown
“Rolls-Royce had a good start to the year, with all three divisions performing well over the first quarter. In Civil Aerospace, there were concerns that the Middle East conflict would reduce the time its engines spent in the air, weighing on revenues. However, engine flying hours are still tracking in line with management’s guidance. That saw full-year guidance reiterated, with underlying operating profits and free cash flow expected to land between £4.0-4.2bn and £3.6-3.8bn, respectively.
Looking ahead to next week’s half-year results, expect flying hours to continue tracking in line with guidance, albeit at the bottom end. But rising defence budgets and growing power demand from data centres in its Defence and Power Systems businesses should drive strong growth. As a result, first-half underlying operating profits are expected to grow by around 10% to £1.9bn.”
Among those currently scheduled to release results next week:
27 July | |
|---|---|
AstraZeneca* | Q2 Results |
Cranswick | Q1 Trading Statement |
Vodafone* | Q1 Trading Statement |
28 July | |
|---|---|
Barclays* | Half Year Results |
Bodycote | Half Year Results |
Coats Group | Half Year Results |
Coca-Cola* | Q2 Results |
Croda International* | Half Year Results |
Games Workshop | Full Year Results |
GSK* | Q2 Results |
Inchcape | Half Year Results |
Man Group | Half Year Results |
Paypal* | Q2 Results |
SSP | Q3 Trading Statement |
Unilever* | Half Year Results |
Unite Group | Half Year Results |
Visa* | Q3 Results |
29 July | |
|---|---|
Aberdeen Group | Half Year Results |
Airbus* | Half Year Results |
Aston Martin* | Half Year Results |
Breedon Group | Half Year Results |
Glencore | Q2 Production Report |
Greggs* | Half Year Results |
International Personal Finance | Half Year Results |
Lancashire Holdings | Half Year Results |
Meta* | Q2 Results |
Microsoft* | Q4 Results |
Paragon Banking Group | Q3 Trading Statement |
Rathbones Group | Half Year Results |
Reckitt* | Half Year Results |
Rio Tinto* | Half Year Results |
Sage Group | Half Year Results |
Shaftesbury Capital | Half Year Results |
St James's Place | Half Year Results |
Standard Chartered* | Half Year Results |
Weir Group | Half Year Results |
30 July | |
|---|---|
Amazon* | Q2 Results |
Anglo American* | Half Year Results |
Apple* | Q3 Results |
BAE Systems* | Half Year Results |
British American Tobacco* | Half Year Results |
Drax Group | Half Year Results |
Elementis | Half Year Results |
Endeavour Mining | Q2 Results |
Greencoat UK Wind | Half Year Results |
Haleon* | Half Year Results |
Hammerson | Half Year Results |
Helios Towers | Half Year Results |
Informa | Half Year Results |
Lloyds* | Half Year Results |
London Stock Exchange Group* | Half Year Results |
Magnum Ice Cream Company* | Half Year Results |
Mastercard* | Q2 Results |
Mondi | Half Year Results |
Oakley Capital Investments | Q2 Trading Statement |
Pets at home | Q1 Trading Statement |
Rentokil Initial | Half Year Results |
Rolls-Royce* | Half Year Results |
Schroders | Half Year Results |
SEGRO | Half Year Results |
Shell* | Q2 Results |
Vesuvius | Half Year Results |
31 July | |
|---|---|
Cameco* | Q2 Results |
IG Group | Half Year Results |
IMI | Half Year Results |
International Consolidated Airlines Group* | Half Year Results |
Intertek Group | Half Year Results |
ITV* | Half Year Results |
Melrose Industries* | Half Year Results |
NatWest* | Half Year Results |
Pearson | Half Year Results |
RHI Magnesita | Half Year Results |
Rightmove | Half Year Results |
Taylor Wimpey* | Half Year Results |
*Events on which we will be updating investors
Notes to Editors
HL is the UK’s largest investment and savings platform for private investors and more than 2.2 million clients trust us with £205 billion (as of June 2026).
We help Britain build wealth, with confidence. Our promise is simple: to provide the best products, the best support and the best value. Founded in 1981, we’ve been helping people save and invest for a better financial future for more than four decades. We offer a lifelong, secure home for our clients’ investments and savings, combining great value with outstanding service, to make managing your money easier at every stage of life.
Our award-winning Savings & Resilience Barometer measures the nation’s financial resilience across our 5 to Thrive pillars, equipping people with the tools they need to strengthen their financial futures.
Saving and investing is for the whole family, and to support intergenerational wealth transfer, we’ve removed all platform charges and share dealing fees on our Junior ISA, meaning kids go free, and we’ve reduced the platform fee on our Lifetime ISA to 0.25%, supporting those savings for their first home or for retirement.
Regular saving into all funds, FTSE 350 shares, and selected investment trusts and ETFs is free.
Our clients also have access to the most comprehensive pension and retirement solution, including SIPP accounts, SIPP Income Drawdown, UFPLS payments and annuities, as well as over 14,000 investment options across funds, shares, ETFs, investment trusts, bonds and gilts.
HL Active Savings is the UK's largest retail cash savings platform that lets savers easily make more of their money and the HL Cash ISA allows savers to manage their Cash ISA portfolio across multiple banks, all within one account.
